Biolinq Shine Receives Landmark FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes image
2 min read

Biolinq Shine Receives Landmark FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes

Pharm'Up
Biolinq Inc. has achieved a significant milestone in diabetes management with the FDA granting De Novo classification...
Read More Read more about Biolinq Shine Receives Landmark FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes
Anito-cel CAR T-Cell Therapy Delivers Deep, Durable Responses and High MRD-Negativity in Relapsed/Refractory Multiple Myeloma image
2 min read

Anito-cel CAR T-Cell Therapy Delivers Deep, Durable Responses and High MRD-Negativity in Relapsed/Refractory Multiple Myeloma

Pharm'Up
New data presented at the 2025 International Myeloma Society Annual Meeting in Toronto, Canada, has revealed that...
Read More Read more about Anito-cel CAR T-Cell Therapy Delivers Deep, Durable Responses and High MRD-Negativity in Relapsed/Refractory Multiple Myeloma
PCSK9 Inhibitors, Including Inclisiran, Show Sustained and Significant Lipid Reduction in Familial Hypercholesterolemia image
2 min read

PCSK9 Inhibitors, Including Inclisiran, Show Sustained and Significant Lipid Reduction in Familial Hypercholesterolemia

Pharm'Up
A comprehensive new systematic review and meta-analysis published in Open Heart has affirmed the strong and sustained...
Read More Read more about PCSK9 Inhibitors, Including Inclisiran, Show Sustained and Significant Lipid Reduction in Familial Hypercholesterolemia
Historic Breakthrough Dr. Reddy’s, Unitaid, CHAI, and Wits RHI Partner to Deliver Affordable Injectable HIV Prevention (Lenacapavir) to LMICs at $40/Year image
3 min read

Historic Breakthrough Dr. Reddy’s, Unitaid, CHAI, and Wits RHI Partner to Deliver Affordable Injectable HIV Prevention (Lenacapavir) to LMICs at $40/Year

Pharm'Up
In a landmark global health collaboration, the revolutionary injectable HIV prevention tool, lenacapavir, is set to become...
Read More Read more about Historic Breakthrough Dr. Reddy’s, Unitaid, CHAI, and Wits RHI Partner to Deliver Affordable Injectable HIV Prevention (Lenacapavir) to LMICs at $40/Year
Alkem Laboratories Launches Pertuza (Pertuzumab Biosimilar) in India to Boost Access to HER2-Positive Breast Cancer Treatment image
2 min read

Alkem Laboratories Launches Pertuza (Pertuzumab Biosimilar) in India to Boost Access to HER2-Positive Breast Cancer Treatment

Pharm'Up
Alkem Laboratories Ltd. has officially announced the launch of Pertuza injection 420mg/14mL, an indigenously-developed and manufactured biosimilar...
Read More Read more about Alkem Laboratories Launches Pertuza (Pertuzumab Biosimilar) in India to Boost Access to HER2-Positive Breast Cancer Treatment

Read These Too

Pharmup 21
2 min read

Hepatitis A: Acute Viral Infection and Prevention

Pharm'Up
Pharmup 20
1 min read

Hepatitis: Understanding Liver Inflammation and Its Causes

Pharm'Up
Pharmup 19
1 min read

Liver Transplantation: A Lifesaving Procedure

Pharm'Up
Pharmup 18
1 min read

Understanding Hemorrhoids: Causes, Symptoms, and Care

Pharm'Up